A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors

Summary

The purpose of the study is to evaluate the efficacy, safety, tolerability and pharmacokinetic (PK) profile of prophylactic SerpinPC in participants with Hemophilia B with inhibitors, as part of the SerpinPC registrational program.

Timeline

Start

2023-07-28

Primary completion

2024-11-14

Completion

2025-02-24

Outcome

Outcome not reported

Stopped (Business): “Study terminated due to business and strategic decision”

Drugs

Indications